Financhill
Sell
35

RXRX Quote, Financials, Valuation and Earnings

Last price:
$4.40
Seasonality move :
16.58%
Day range:
$4.38 - $4.69
52-week range:
$3.79 - $12.36
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
23.22x
P/B ratio:
1.91x
Volume:
23.3M
Avg. volume:
18.7M
1-year change:
-51.11%
Market cap:
$1.8B
Revenue:
$58.5M
EPS (TTM):
-$1.77

Earnings Data

Next earnings date for RXRX
Aug 08
2025
Most recent earnings per share
-$0.50
Beat by $0.02
(May 5/2025)
Consensus Estimate
-$0.52
(May 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RXRX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/08/2025 Q2 $16.2M -- -- -$0.36 --
05/05/2025 Q1 $18.1M $14.8M -$0.50 -$0.52 $0.02
02/28/2025 Q4 $19M $4.5M -$0.53 -$0.42 -$0.11
11/06/2024 Q3 $29.8M $26.1M -$0.34 -$0.33 -$0.01
08/08/2024 Q2 $13.3M $14.4M -$0.40 -$0.38 -$0.02
05/09/2024 Q1 $13.1M $13.5M -$0.39 -$0.43 $0.04
02/27/2024 Q4 $20.4M $10.6M -$0.42 -$0.45 $0.03
11/09/2023 Q3 -- -- -$0.43 -$0.39 -$0.04
08/08/2023 Q2 -- -- -$0.38 -$0.37 -$0.01
05/08/2023 Q1 -- -- -$0.34 -$0.35 $0.01
02/27/2023 Q4 -- -- -$0.31 -$0.24 -$0.07
11/08/2022 Q3 -- -- -$0.35 -$0.38 $0.03
08/09/2022 Q2 -- -- -$0.38 -$0.37 -$0.01
05/10/2022 Q1 -- -- -$0.33 $0.51 -$0.84
03/23/2022 Q4 -- -- -$0.38 -$0.31 -$0.07
11/10/2021 Q3 -- -- -$0.28 -$0.28 $0.00
08/13/2021 Q2 -- -- -$0.31 -$0.24 -$0.07
03/31/2021 Q1 -- -- -$0.20 -$0.23 $0.04
12/31/2020 Q4 -- -- -$0.23 -- --
06/30/2020 Q2 -- -- -$0.17 -- --
03/31/2020 Q1 -- -- -$0.16 -- --

Recursion Pharmaceuticals Earnings Questions

  • How Much did Recursion Pharmaceuticals Generate in Revenue Last Quarter?

    Recursion Pharmaceuticals reported $14.8M worth of top line sales in its most recent quarter.

  • Did Recursion Pharmaceuticals Beat Earnings Last Quarter?

    Recursion Pharmaceuticals announced earnings per share of -$0.50 which represents a beat of analyst forecast a -$0.52 per share.

  • Is Recursion Pharmaceuticals Profitable?

    Recursion Pharmaceuticals reported -$7M that represents -$0.02 per share over the last quarter.

  • What is the Analyst Consensus for Recursion Pharmaceuticals EPS Next Year?

    Recursion Pharmaceuticals's earnings are forecast to decrease from -$1.69 per share to -$1.54 per share next year representing a decrease of -13.74%.

  • When is Recursion Pharmaceuticals's Earnings Date?

    Recursion Pharmaceuticals's next earnings date is August 8, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Microsoft Stock Outlook, Azure & AI as Drivers of Long-Term Growth
Microsoft Stock Outlook, Azure & AI as Drivers of Long-Term Growth

Microsoft (NASDAQ:MSFT) has been among the top growth stocks of…

Is Tesla Stock Overvalued or a Buy for the Next Decade?
Is Tesla Stock Overvalued or a Buy for the Next Decade?

Shares of EV major Tesla (NASDAQ:TSLA) have experienced extreme volatility…

Is Apple Stock Undervalued or Overvalued?
Is Apple Stock Undervalued or Overvalued?

For many years, Apple (NASDAQ:AAPL) was just about the perfect…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
68
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
80
SBET alert for May 29

SharpLink Gaming [SBET] is up 48.29% over the past day.

Buy
100
BOX alert for May 29

Box [BOX] is down 0.57% over the past day.

Sell
22
OKTA alert for May 29

Okta [OKTA] is up 1.32% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock